Helminthiasis

30 registered clinical trials studyying Helminthiasis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Co-administration of IVM and ALB in School-based Deworming in Uganda NCT06497075	Jennifer Keiser	—
Completed	Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets NCT05048485	Boston Medical Center	—
Withdrawn	Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection NCT02636803	Johns Hopkins Bloomberg School of Public Health	Phase 2
Completed	Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients NCT04041453	Alejandro Krolewiecki	Phase 2
Completed	Urine Albendazole Levels for Coverage Assessment NCT04041427	Universidad Nacional de Salta	N/A
Unknown	Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene Education NCT04227834	Universitas Sumatera Utara	N/A
Completed	Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) NCT03014167	University of Washington	Phase 3
Completed	Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, NCT03173742	Insud Pharma	Phase 1
Completed	Design and Clinical Evaluation of a School Meal With Deworming Properties NCT02725255	Kenya Medical Research Institute	Phase 2 / Phase 3
Completed	Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya NCT02397772	London School of Hygiene and Tropical Medicine	Phase 4
Completed	The Effect of an Urban Sanitation Intervention on Child Health NCT02362932	London School of Hygiene and Tropical Medicine	N/A
Completed	Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health NCT02396407	University of California, Berkeley	N/A
Completed	Assessment of Drug Efficacy of Local Albendazole NCT02420574	University Ghent	N/A
Completed	The Longevity of Trichuris Trichiura Colonization NCT04227925	University of Aarhus	—
Completed	Taenia Solium Control Case Study in Zambia NCT01368354	University of Zambia	N/A
Completed	Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population NCT01755637	GlaxoSmithKline	Phase 1
Terminated	An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths NCT01271049	Mondelēz International, Inc.	N/A
Unknown	Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren i NCT01459146	Navrongo Health Research Centre, Ghana	Phase 4
Unknown	Management of Soil-transmitted Helminthiasis and Strongyloidiasis NCT01308268	Universidad Nacional de Salta	N/A
Completed	Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora NCT01192802	Albert Schweitzer Hospital	Phase 4
Terminated	Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa? NCT00817713	Swiss Tropical & Public Health Institute	N/A
Completed	Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression NCT00507221	University of Washington	N/A
Completed	Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis NCT00469495	Hospital Universitário Professor Edgard Santos	N/A
Completed	Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes NCT00463593	DBL -Institute for Health Research and Development	—
Completed	Relative Efficacy of Two Regimens of Ante-helminthic Treatment NCT00367627	International Centre for Diarrhoeal Disease Research, Bangladesh	N/A
Completed	Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation NCT00130910	University of Washington	N/A
Completed	Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfa NCT02385058	Janssen-Cilag Ltd.	Phase 4
Completed	Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections NCT00004996	National Institute of Allergy and Infectious Diseases (NIAID)	—
Recruiting	Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia NCT00001406	National Institute of Allergy and Infectious Diseases (NIAID)	—
Recruiting	Host Response to Infection and Treatment in Filarial Diseases NCT00001230	National Institute of Allergy and Infectious Diseases (NIAID)	—